Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

Show notes
(00:32)
 Could you please provide us a little information about your background?

 

(01:46)
 Could you please give the audience a brief overview of this assay?

 

(03:45)
 Which patients should have this testing and when should it be performed?

 

(06:39)
 How are the results used in patient care?

 

(08:51)
 What alternative test options are available and how do they compare to our test?